1. Home
  2. TOPP vs INKT Comparison

TOPP vs INKT Comparison

Compare TOPP & INKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TOPP
  • INKT
  • Stock Information
  • Founded
  • TOPP 2014
  • INKT 2017
  • Country
  • TOPP United States
  • INKT United States
  • Employees
  • TOPP N/A
  • INKT N/A
  • Industry
  • TOPP
  • INKT Medicinal Chemicals and Botanical Products
  • Sector
  • TOPP
  • INKT Health Care
  • Exchange
  • TOPP NYSE
  • INKT Nasdaq
  • Market Cap
  • TOPP 26.6M
  • INKT 75.7M
  • IPO Year
  • TOPP 2025
  • INKT 2021
  • Fundamental
  • Price
  • TOPP $2.15
  • INKT $16.54
  • Analyst Decision
  • TOPP
  • INKT Hold
  • Analyst Count
  • TOPP 0
  • INKT 3
  • Target Price
  • TOPP N/A
  • INKT $37.50
  • AVG Volume (30 Days)
  • TOPP 12.5K
  • INKT 3.0M
  • Earning Date
  • TOPP 08-11-2025
  • INKT 08-12-2025
  • Dividend Yield
  • TOPP N/A
  • INKT N/A
  • EPS Growth
  • TOPP N/A
  • INKT N/A
  • EPS
  • TOPP N/A
  • INKT N/A
  • Revenue
  • TOPP $16,117,227.00
  • INKT N/A
  • Revenue This Year
  • TOPP N/A
  • INKT N/A
  • Revenue Next Year
  • TOPP N/A
  • INKT N/A
  • P/E Ratio
  • TOPP N/A
  • INKT N/A
  • Revenue Growth
  • TOPP 0.44
  • INKT N/A
  • 52 Week Low
  • TOPP $0.97
  • INKT $4.56
  • 52 Week High
  • TOPP $4.50
  • INKT $76.00
  • Technical
  • Relative Strength Index (RSI)
  • TOPP N/A
  • INKT 49.27
  • Support Level
  • TOPP N/A
  • INKT $16.02
  • Resistance Level
  • TOPP N/A
  • INKT $20.25
  • Average True Range (ATR)
  • TOPP 0.00
  • INKT 8.31
  • MACD
  • TOPP 0.00
  • INKT -1.23
  • Stochastic Oscillator
  • TOPP 0.00
  • INKT 0.86

About TOPP TOPPOINT HOLDINGS INC

Toppoint Holdings Inc is a truckload services and solutions provider focused on the recycling export supply chain. The company operates in one operating segment where it derives its revenues from the delivery of truckload services.

About INKT MiNK Therapeutics Inc.

MiNK Therapeutics Inc is a clinical-stage biopharmaceutical company pioneering the discovery, development, and commercialization of allogeneic invariant natural killer T (iNKT) cell therapies to treat cancer and other immune-mediated diseases. The company is advancing a pipeline of both native and next generation engineered iNKT programs, with a platform designed to facilitate scalable and reproducible manufacturing for off-the-shelf delivery.

Share on Social Networks: